Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 55, Number 10, November 28, 2000
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gambardella, A.
Right arrow Articles by Quattrone, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gambardella, A.
Right arrow Articles by Quattrone, A.
Neurology 2000;55:1467-1471
© 2000 American Academy of Neurology


Articles

A new locus for autosomal dominant nocturnal frontal lobe epilepsy maps to chromosome 1

A. Gambardella, MD;, G. Annesi, PhD;, M. De Fusco, BS;, A. Patrignani, BS;, U. Aguglia, MD;, F. Annesi, PhD;, A. A. Pasqua, PhD;, P. Spadafora, PhD;, R. L. Oliveri, MD, MSc;, P. Valentino, MD;, M. Zappia, MD;, A. Ballabio, MD;, G. Casari, PhD; and A. Quattrone, MD

From the Institute of Neurology (Drs. Gambardella, Aguglia, Oliveri, Valentino, Zappia, and Quattrone), School of Medicine, Catanzaro; Institute of Experimental Medicine and Biotechnology (Drs. Gambardella, G. Annesi, F. Annesi, Pasqua, Spadafora, Oliveri, and Quattrone), National Research Council, Piano Lago di Mangone–Cosenza; and Telethon Institute of Genetics and Medicine (TIGEM) (Drs. De Fusco, Patrignani, Ballabio, and Casari), San Raffaele Biomedical Science Park, Milan, Italy.

Address correspondence to Professor Aldo Quattrone, Cattedra ed U.O. di Neurologia, Facoltà di Medicina e Chirurgia, Università "Magna Graecia" Catanzaro, Policlinico Mater Domini, Via Tommaso Campanella, 88100 Catanzaro, Italy; e-mail: neurol.unicz{at}interbusiness.it

BACKGROUND: Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is caused by mutations in the {alpha}4 subunit of the neuronal nicotinic acetylcholine receptor (CHRNA4) gene, mapping on chromosome 20q13.2. A second ADNFLE locus was mapped on chromosome 15q24.

OBJECTIVE: To report a new third ADNFLE locus on chromosome 1 in a large Italian family.

METHODS: The authors performed a clinical and genetic study in a large, three-generation ADNFLE family from southern Italy, including eight affected individuals and three obligate carriers.

RESULTS: The age at onset of seizures was around 9 years of age and all affected individuals manifested nocturnal partial seizures of frontal lobe origin. Interictal awake and sleep EEG recordings showed no definite epileptiform abnormalities in most patients. Ictal video-EEG showed that the attacks were partial seizures with a frontal lobe semiology. Intellectual and neurologic examinations, and brain CT or MRI results were always normal. Carbamazepine was effective in all treated patients. Exclusion mapping of the known loci linked to ADNFLE—ENFL1, and ENFL2, on chromosomes 20q13.2 and 15q24—was performed on the pedigree before starting the genome-wide linkage analysis. The whole genome scan mapping allowed the identification of a new ADNFLE locus spanning the pericentromeric region of chromosome 1.

CONCLUSIONS: The authors provided evidence for a third locus associated to autosomal dominant nocturnal frontal lobe epilepsy on chromosome 1. Among the known genes mapping within this critical region, the ß2 subunit of the nicotinic receptor (CHRNB2) represents the most obvious candidate.




This article has been cited by other articles:


Home page
Therapeutic Advances in Neurological DisordersHome page
I. Unterberger and E. Trinka
Review: Diagnosis and treatment of paroxysmal dyskinesias revisited
Therapeutic Advances in Neurological Disorders, September 1, 2008; 1(2): 67 - 74.
[Abstract] [PDF]


Home page
NeurologyHome page
M. K. Bruno, H.-Y Lee, G.W.J. Auburger, A. Friedman, J. E. Nielsen, A. E. Lang, E. Bertini, P. Van Bogaert, Y. Averyanov, M. Hallett, et al.
Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia
Neurology, May 22, 2007; 68(21): 1782 - 1789.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
F. Picard, D. Bruel, D. Servent, W. Saba, C. Fruchart-Gaillard, M.-A. Schollhorn-Peyronneau, D. Roumenov, E. Brodtkorb, S. Zuberi, A. Gambardella, et al.
Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study
Brain, August 1, 2006; 129(8): 2047 - 2060.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H.-Y. Lee, Y. Xu, Y. Huang, A. H. Ahn, G. W.J. Auburger, M. Pandolfo, H. Kwiecinski, D. A. Grimes, A. E. Lang, J. E. Nielsen, et al.
The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway
Hum. Mol. Genet., December 15, 2004; 13(24): 3161 - 3170.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W. Liu, J. Seto, G. Donovan, and M. Toth
Jerky, a Protein Deficient in a Mouse Epilepsy Model, Is Associated with Translationally Inactive mRNA in Neurons
J. Neurosci., January 1, 2002; 22(1): 176 - 182.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. J. Ptacek
Ligand-gated ion channelopathies: Mutations in different genes causing one disease
Neurology, November 28, 2000; 55(10): 1429 - 1430.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.